GlycoMimetics, Inc.
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inh…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
GlycoMimetics, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
GlycoMimetics, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of GlycoMimetics, Inc..